BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rosenheck J, Pietras C, Cantu E. Early Graft Dysfunction after Lung Transplantation. Curr Pulmonol Rep 2018;7:176-87. [PMID: 31548919 DOI: 10.1007/s13665-018-0213-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Nykänen AI, Mariscal A, Duong A, Estrada C, Ali A, Hough O, Sage A, Chao BT, Chen M, Gokhale H, Shan H, Bai X, Zehong G, Yeung J, Waddell T, Martinu T, Juvet S, Cypel M, Liu M, Davies JE, Keshavjee S. Engineered mesenchymal stromal cell therapy during human lung ex vivo lung perfusion is compromised by acidic lung microenvironment. Mol Ther Methods Clin Dev 2021;23:184-97. [PMID: 34703841 DOI: 10.1016/j.omtm.2021.05.018] [Reference Citation Analysis]
2 Magouliotis DE, Spiliopoulos K, Fergadi MP, Athanassiadi K. Novel Candidate Genes of the Bcl-2 Interactome as Mediators of Apoptosis in Lung Transplant Recipients With Primary Graft Dysfunction. Prog Transplant 2020;30:184-6. [PMID: 32238051 DOI: 10.1177/1526924820913517] [Reference Citation Analysis]
3 Van Slambrouck J, Van Raemdonck D, Vos R, Vanluyten C, Vanstapel A, Prisciandaro E, Willems L, Orlitová M, Kaes J, Jin X, Jansen Y, Verleden GM, Neyrinck AP, Vanaudenaerde BM, Ceulemans LJ. A Focused Review on Primary Graft Dysfunction after Clinical Lung Transplantation: A Multilevel Syndrome. Cells 2022;11:745. [PMID: 35203392 DOI: 10.3390/cells11040745] [Reference Citation Analysis]